These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

495 related items for PubMed ID: 6797816

  • 1. Oral thyrotropin-releasing hormone (TRH) test in acromegaly.
    Marek J, Límanová Z, Srámková J.
    Endokrinologie; 1981 Oct; 78(1):57-66. PubMed ID: 6797816
    [Abstract] [Full Text] [Related]

  • 2. The pituitary-thyroid axis in acromegaly.
    Eskildsen PC, Kruse A, Kirkegaard C.
    Horm Metab Res; 1988 Dec; 20(12):755-7. PubMed ID: 3146541
    [Abstract] [Full Text] [Related]

  • 3. Naloxone influence on the growth hormone, prolactin and thyrotropin response to thyrotropin releasing hormone in acromegalic patients.
    De Marinis L, Mancini A, Zuppi P, Fiumara C, Conte G, Sammartano L, Fabrizi ML, Valle D.
    Exp Clin Endocrinol Diabetes; 1996 Dec; 104(1):67-71. PubMed ID: 8750573
    [Abstract] [Full Text] [Related]

  • 4. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH, Sobieszczyk S, Ain KB, Refetoff S.
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [Abstract] [Full Text] [Related]

  • 5. Effects of repetitive administration of thyrotropin-releasing hormone at short intervals in acromegaly.
    Losa M, Alba-Roth J, Sobieszczyk S, Schopohl J, Müller OA, von Werder K.
    Acta Endocrinol (Copenh); 1989 Mar; 120(3):383-9. PubMed ID: 2494827
    [Abstract] [Full Text] [Related]

  • 6. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP, Jacobs LS, Hoffman W, Daughaday WH, Blizzard RM.
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J, Felt V.
    Endokrinologie; 1976 Aug; 68(2):175-82. PubMed ID: 827434
    [Abstract] [Full Text] [Related]

  • 8. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ, Utiger RD.
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [Abstract] [Full Text] [Related]

  • 9. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
    Pieters GF, van Liessum PA, Smals AG, van Gennep JA, Benraad TJ, Kloppenborg PW.
    Acta Endocrinol Suppl (Copenh); 1987 Sep; 286():9-18. PubMed ID: 2892339
    [Abstract] [Full Text] [Related]

  • 10. Central hypothyroidism--various types of TSH responses to TRH stimulation.
    Trejbal D, Sulla I, Trejbalová L, Lazúrová I, Schwartz P, Machánová Y.
    Endocr Regul; 1994 Mar; 28(1):35-40. PubMed ID: 7949012
    [Abstract] [Full Text] [Related]

  • 11. Disparity of thyrotropin (TSH) and prolactin responses to TSH-releasing hormone in obesity.
    Donders SH, Pieters GF, Heevel JG, Ross HA, Smals AG, Kloppenborg PW.
    J Clin Endocrinol Metab; 1985 Jul; 61(1):56-9. PubMed ID: 3923032
    [Abstract] [Full Text] [Related]

  • 12. Effect of dexamethasone on prolactin and TSH responses to TRH and metoclopramide in man.
    Sowers JR, Carlson HE, Brautbar N, Hershman JM.
    J Clin Endocrinol Metab; 1977 Feb; 44(2):237-41. PubMed ID: 402375
    [Abstract] [Full Text] [Related]

  • 13. Serum thyrotropin response to combined arginine and thyrotropin-releasing hormone administration provides evidence for an altered somatostatinergic tone in acromegaly.
    Merola B, Colao A, Cataldi M, Rossi E, Longobardi S, Caruso E, Lombardi G.
    Horm Res; 1992 Feb; 37(1-2):7-13. PubMed ID: 1356902
    [Abstract] [Full Text] [Related]

  • 14. Effects of acute infusion of erythropoietin on paradoxical responses of growth hormone to thyrotropin-releasing hormone in acromegalic patients.
    Díez JJ, Iglesias P, Sastre J, Gómez-Pan A.
    Eur J Endocrinol; 2000 Aug; 143(2):203-11. PubMed ID: 10913939
    [Abstract] [Full Text] [Related]

  • 15. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone.
    Andreassen B, Huth J, Tyson JE.
    Am J Obstet Gynecol; 1979 Nov 15; 135(6):737-42. PubMed ID: 115316
    [Abstract] [Full Text] [Related]

  • 16. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.
    Sack J, Shafrir Y, Urbach D, Amado O.
    Pediatr Res; 1985 Oct 15; 19(10):1037-9. PubMed ID: 3932951
    [Abstract] [Full Text] [Related]

  • 17. Oral administration of TRH in puerperal women: effect on insufficient lactation, thyroid hormones and on the responses of TSH and prolactin to intravenous TRH.
    Ylikorkala O, Kivinen S, Kauppila A.
    Acta Endocrinol (Copenh); 1980 Apr 15; 93(4):413-8. PubMed ID: 6770567
    [Abstract] [Full Text] [Related]

  • 18. Contradictory clinical implications between paradoxical growth hormone responses to thyrotropin-releasing hormone and those to vasoactive intestinal peptide and luteinizing hormone-releasing hormone in acromegaly.
    Watanobe H, Tamura T, Sasaki S, Takebe K.
    Neuropeptides; 1993 Dec 15; 25(6):363-75. PubMed ID: 8127416
    [Abstract] [Full Text] [Related]

  • 19. The influence of long-term low dose thyrotropin-releasing hormone infusions on serum thyrotropin and prolactin concentrations in man.
    Spencer CA, Greenstadt MA, Wheeler WS, Kletzky OA, Nicoloff JT.
    J Clin Endocrinol Metab; 1980 Oct 15; 51(4):771-5. PubMed ID: 6774994
    [Abstract] [Full Text] [Related]

  • 20. Thyrotropin-releasing hormone in critical illness: from a dopamine-dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations.
    Van den Berghe G, de Zegher F, Vlasselaers D, Schetz M, Verwaest C, Ferdinande P, Lauwers P.
    Crit Care Med; 1996 Apr 15; 24(4):590-5. PubMed ID: 8612408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.